Evaluating atrial natriuretic peptide-induced cGMP production by particulate guanylyl cyclase stimulation in vitro and in vivo.
Hamet
P
P
Tremblay
J
J
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D000302:Adrenal Cortex / Q000378:metabolism; D000818:Animals; D009320:Atrial Natriuretic Factor / Q000378:metabolism / Q000494:pharmacology*; D005576:Colforsin / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism; D006152:Cyclic GMP / Q000032:analysis / Q000097:blood / Q000378:metabolism*; D004285:Dogs; D006162:Guanylate Cyclase / Q000378:metabolism*; D006801:Humans; D007678:Kidney Glomerulus / Q000201:enzymology; D007700:Kinetics; D009131:Muscle, Smooth, Vascular / Q000378:metabolism; D009599:Nitroprusside / Q000494:pharmacology; D011863:Radioimmunoassay / Q000379:methods; D051381:Rats; D017461:Receptors, Atrial Natriuretic Factor; D011956:Receptors, Cell Surface / Q000378:metabolism*
D011956:Receptors, Cell Surface; D009599:Nitroprusside; D005576:Colforsin; D009320:Atrial Natriuretic Factor; D000242:Cyclic AMP; D006162:Guanylate Cyclase; D017461:Receptors, Atrial Natriuretic Factor; D006152:Cyclic GMP; D015056:1-Methyl-3-isobutylxanthine